W.R. Grace has formally opened an expansion of the pharmaceutical CDMO expansion project it began 21 months ago at its site in South Haven, Michigan. The expansion has added 25% more capacity, including a new 15 m3 Hastelloy centrifuge and three 15 m3 multi-purpose chemical reactors.
W. R. Grace & Co. has announced plans to expand its CDMO facility in South Haven, Michigan, by January 2024. It will add an 18 m3 multi-purpose glass-lined and stainless steel reactor train to two existing trains of the same size, as well as a Hastelloy centrifuge to facilitate product isolation.
W.R. Grace & Co. has agreed to acquire the Fine Chemistry Services (FCS) business of its fellow US speciality chemicals company, Albemarle, in a deal that is expected to close in Q2, subject to regulatory approvals and other customary conditions. This will bring Grace sites at Tyrone, Pennsylvania, and South Haven, Michigan. FCS will fit within Pharma & Consumer, which Grace described as “the largest, fastest growing and most profitable sub-segment” in its Materials Technologies business.
